IRIS
PORZIO, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.027
EU - Europa 1.630
AS - Asia 825
OC - Oceania 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
Totale 5.498
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.023
IE - Irlanda 700
CN - Cina 426
TR - Turchia 356
DE - Germania 230
UA - Ucraina 186
SE - Svezia 132
GB - Regno Unito 123
IT - Italia 97
FI - Finlandia 66
FR - Francia 48
BE - Belgio 21
VN - Vietnam 17
IN - India 9
RU - Federazione Russa 6
CA - Canada 4
EU - Europa 4
AU - Australia 3
NL - Olanda 3
SG - Singapore 3
BG - Bulgaria 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
ZA - Sudafrica 2
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
HK - Hong Kong 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
MC - Monaco 1
MK - Macedonia 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 5.498
Salva come PNG Salva come JPEG
Città #
Chandler 712
Jacksonville 705
Dublin 700
Izmir 156
Ann Arbor 141
Wilmington 113
Nanjing 110
Lawrence 102
Princeton 102
Boardman 99
Ashburn 92
San Mateo 72
New York 70
Beijing 63
Bremen 49
Dearborn 43
Shenyang 40
Nanchang 37
Seattle 34
Milan 29
Woodbridge 27
Jinan 25
L'aquila 25
Brussels 21
Des Moines 21
Hebei 20
Mountain View 20
Tianjin 20
Düsseldorf 19
Kunming 18
Dong Ket 16
Verona 15
Norwalk 14
Ningbo 13
Jiaxing 12
Changsha 11
Zhengzhou 10
Philadelphia 9
Tappahannock 8
Guangzhou 7
Helsinki 7
London 7
Hangzhou 6
Pune 6
San Francisco 6
Taizhou 6
Fremont 5
Lanzhou 5
Auburn Hills 3
Ciampino 3
Edinburgh 3
Falls Church 3
Frankfurt am Main 3
Seveso 3
Stockholm 3
Amsterdam 2
Baotou 2
Fuzhou 2
Haikou 2
Hefei 2
Houston 2
Orange 2
Qingdao 2
Sofia 2
Sydney 2
Tarcento 2
Ajax 1
Atlanta 1
Belgrade 1
Birmingham 1
Budapest 1
Buenos Aires 1
Cairo 1
Canberra 1
Central 1
Centurion 1
Changchun 1
Chengdu 1
Chieti 1
Città Sant'Angelo 1
Cochabamba 1
Copenhagen 1
Guiyang 1
Hanoi 1
Jakarta 1
La Jolla 1
Lisbon 1
Los Angeles 1
Manchester 1
Manila 1
Minsk 1
Monaco 1
Montreal 1
Munich 1
Narcao 1
Nelson 1
Nicosia 1
Nizhniy Novgorod 1
Oslo 1
Osnabrück 1
Totale 3.925
Salva come PNG Salva come JPEG
Nome #
Age differences in the last week of life in advanced cancer patients followed at home 93
Efficacy of pregabalin in the management of cetuximab-related itch 91
Epidemiology and Characteristics of Episodic Breathlessness In Advanced Cancer Patients: An Observational Study 90
Does pain intensity predict a poor opioid response in cancer patients? 84
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 84
Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients 82
Assessment and treatment of symptoms among italian medical oncologists 80
The supportive care task force at the University of L'Aquila: 2-years experience 80
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 80
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 77
Pain evaluation and management: a survey of Italian radiotherapists 74
Tapentadol in cancer pain management: a prospective open-label study 74
Palliative care in advanced cancer patients: how and when? And where? 73
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 71
Safety and Effectiveness of Intravenous Morphine for Episodic Breakthrough Pain in Patients Receiving Transdermal Buprenorphine 71
Pain intensity as prognostic factor in cancer pain management 70
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 70
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 69
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 69
Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study 69
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 69
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 68
Tools for Identifying Cancer Pain of Predominantly Neuropathic Origin and Opioid Responsiveness in Cancer Patients 68
Validation of the pap score in advanced cancer patients who are candidates for palliative chemotherapy 68
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 67
Effective analgesic score: a "marker" of the effects of chemotherapy on pain in advanced cancer patients? 67
The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients 67
Palliative sedation in patients with advanced cancer followed at home: A systematic review 67
Breakthrough pain in oncology: A longitudinal study 65
The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program 64
Morphine in the treatment of incident pain triggered by vinorelbine infusion 63
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting 63
Dosing fentanyl buccal tablet for breakthrough cancer pain: Dose titration versus proportional doses 63
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 62
Pharmacokinetics in pelvic stop-flow infusion and hypoxic pelvic perfusion with and without hemofiltration. 62
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 60
Physical Exercise and Quality of Life in Breast Cancer Survivors 60
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 60
Pattern of symptoms and symptomatic treatment in adults and the aged population: A retrospective analysis of advanced cancer patients followed at home 59
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 59
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 59
Rapid resolution of refractory chemotherapy induced oral mucositis with platelet gel-released supernatant in a pediatric cancer patient: a case report 58
Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies. 58
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 58
Palliative sedation in advanced cancer patients followed at home: A retrospective analysis 58
Pain Characteristics and Analgesic Treatment in an Aged Adult Population: A 4-Week Retrospective Analysis of Advanced Cancer Patients Followed at Home. 57
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 57
Supporto nutrizionale 56
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 55
Tapentadol at medium to high doses in patients previously receiving strong opioids for the management of cancer pain 54
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 54
Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting 53
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 53
Palliative sedation in patients with advanced cancer followed at home: A prospective study 53
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy 52
Emergencies in patients with advanced cancer followed at home 51
Prognostic factors of survival in patients with advanced cancer admitted to home care 51
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 51
Is there a role for neurologist in an oncological home care team? 50
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 50
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 50
Pruritus in a patient with advanced cancer successfully treated with continuous infusion of granisetron 49
Orphan symptoms in advanced cancer patients followed at home 47
Tumori Ginecologici 47
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 47
How do cancer patients receiving palliative care at home die? A descriptive study 46
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 45
Topical menthol for treatment of chemotherapy-induced peripheral neuropathy 45
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 45
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 44
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study 43
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 43
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 43
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 42
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 42
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 42
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 42
Multimodality treatment in metastatic gastric cancer: From past to next future 42
Opioid switching in patients with advanced cancer followed at home. A retrospective analysis 41
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 41
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 40
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 40
Cancer care after natural disaster: Different countries, similar problems 40
Topical morphine in the treatment of painful ulcers 39
Re. “Awareness and consideration of malnutrition among oncologists: Insights from an exploratory survey” 39
Integration between oncology and palliative care: A plan for the next decade? 39
Comment on ‘What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain: Expert Opinion’ 39
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 39
Integration between oncology and palliative care: Does one size fit all? 38
What Is Known about Theragnostic Strategies in Colorectal Cancer 38
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 38
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 36
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 35
Is it possible to teach pain therapy playing basketball? 33
Clinical and psychometric validation of the BreSAS questionnaire for symptom assessment among breast cancer survivors 33
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a web based online survey among Italian experts on supportive care in cancer 29
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 28
Timed-flat infusion of 5-fluorouracil with docetaxel and oxaliplatin as first-line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen 27
Knowledge, attitudes and associated behaviors of young Italian medical oncologists in management of cancer pain: Preliminary data of a National survey 26
Palliative sedation at home: A medical act practicable everywhere 25
Totale 5.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.560
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019263 0 0 0 0 0 0 0 0 0 10 14 239
2019/2020763 116 0 66 7 5 88 199 30 110 35 3 104
2020/2021791 28 104 4 107 100 15 109 7 111 20 156 30
2021/2022469 18 24 46 21 27 6 11 41 36 6 40 193
2022/20232.108 133 151 32 237 192 200 2 137 898 14 61 51
2023/2024345 63 24 22 48 37 114 3 33 1 0 0 0
Totale 5.610